Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  11:37 2022-11-30 am EST
86.48 EUR   -1.94%
11:34aGlobal markets live: Apple, Tesla, Boeing, HP, Intuit...
MS
11:17aEuropean Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
10:13aAll eyes on Powell
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

European shares eke out gains at open as healthcare stocks rebound

08/12/2022 | 03:28am EST
German share price index DAX graph is pictured at the stock exchange in Frankfurt

(Reuters) - European shares eked out gains on Friday at the open after Sanofi and GSK led a rebound in healthcare stocks, with the main STOXX 600 index set for weekly gains.

Sanofi rose 1.6% and GSK added 3.0% after a heavy selloff in the previous session on growing worries about U.S. litigation focused on a heartburn drug that contained a probable carcinogen.

JPMorgan said it sees a stronger buying opportunity for Sanofi versus GSK, adding Sanofi would not be liable for any litigation damages.

The European healthcare sector gained 0.4%, while the STOXX 600 index rose 0.1%.

The main index rose for the second straight day and was set to notch up weekly gains of 1% as a softer-than-expected U.S. inflation reading calmed nerves around the Federal Reserve's monetary policy tightening cycle.

(Reporting by Shreyashi Sanyal in Bengaluru; Editing by Saumyadeb Chakrabarty)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
GSK PLC -0.78% 1406.8 Delayed Quote.-13.74%
SANOFI -1.94% 86.48 Real-time Quote.-0.44%
STOXX EUROPE 600(EUR)(TR) 0.63% 1016.07 Delayed Quote.-8.10%
All news about SANOFI
11:34aGlobal markets live: Apple, Tesla, Boeing, HP, Intuit...
MS
11:17aEuropean Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
10:13aAll eyes on Powell
MS
09:00aUpwardly Revised Q3 GDP Ahead of Powell's Speech Lifts US Equities Higher Premarket
MT
08:52aSANOFI : Credit Suisse remains its Buy rating
MD
08:37aMarketScreener's World Press Review : November 30, 2..
MS
05:59aNorth American Morning Briefing: Powell in Focus as Chin..
DJ
04:26aSanofi's Single-dose Pill Set To Become First Treatment For Deadly Sleeping Sickness Af..
MT
02:01aPress Release : Acoziborole: Investigational single-dose oral treatment raises hope for el..
GL
02:00aPress Release : Acoziborole: Investigational single-dose oral treatment raises hope for el..
GL
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2022 44 229 M 45 733 M 45 733 M
Net income 2022 7 658 M 7 919 M 7 919 M
Net Debt 2022 6 741 M 6 970 M 6 970 M
P/E ratio 2022 14,7x
Yield 2022 4,09%
Capitalization 111 B 114 B 114 B
EV / Sales 2022 2,65x
EV / Sales 2023 2,48x
Nbr of Employees 95 442
Free-Float 87,9%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 88,19 €
Average target price 106,46 €
Spread / Average Target 20,7%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Director
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI-0.44%114 358
JOHNSON & JOHNSON2.93%460 384
ELI LILLY AND COMPANY32.42%345 817
ABBVIE INC.16.84%279 679
PFIZER, INC.-16.19%277 803
NOVO NORDISK A/S19.71%276 497